Influence of liposome composition on paclitaxel entrapment and pH sensitivity of liposomes

International Journal of PharmTech Research

Volumn 1, Issue 3, 2009, Pages 914-917

  Rane, Smita ^a   Prabhakar, Bala ^b  

^a School of Pharmacy and Technology Management   (India)

^b NMIMS UNIVERSITY   (India)

Author keywords

Entrapment efficiency; Liposomes; Paclitaxel; pH sensitivity

Indexed keywords

CHOLESTEROL HYDROGEN SUCCINATE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; LIPID; LIPOSOME; PACLITAXEL; PHOSPHOLIPID; PHOSPHOLIPON 90 G; UNCLASSIFIED DRUG;

ARTICLE; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; PH;

EID: 77953472923     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. G. Appendino, Taxol® (Paclitaxle): Historical and Ecological aspects. Fitoterapia. 45 (1993) 5-27.
2. D.S. Chervinsky, M.L. Brecher, M.J. Hoelcle, Cremophor EL Enhances Taxol Efficacy in a Multidrug Resistant C1300 Nuroblastoma cell line, J. Anticancer Res. 13 (1993) 93-96.
3. L.Webster, M. Linsenmeyer, M. Millward, C. morton, J. Bishop, D. Woodcock, Measurement of Cremophor EL Following Taxol: Plasma Levels Sufficient to Reverse Drug Exclusion mediated by the multidrug resistant Phenotype, J. natl. Cancer Inst. 85 (1993) 1685-1690.
4. M.L. Fjallskog, L. Frii, J. Bergh, Is cremophor, solvent for paclitaxel, cytotoxic?, Lancet 342 (1993) 876.
5. E.K. Rowinsky, E.A. Eisenhauer, V. Chaudry, S.G. Arbuck R.C. Donehower, Clinical toxicities encountered with paclitaxel (Taxol), Semin. Oncol. 20 (1993) 1-15.
6. R.T. Dorr, Pharmacology and toxicology of Cremophor EL diluent, Ann. Pharmacother. 28 (1994) S11-S14.
7. B.R. Goldspiel, Pharmaceutical issues: preparation, administration, stability, and compatibility with other medications, Ann. Pharmacother. 28 (1994) S23-S26
8. D.C. Drummand, M. Zignani, J.C. Leroux, Current status of pH-sensitive liposomes in drug delivery. Prog. Lipid Res. 39 (2002) 409-460.
9. 2+ - induced fusion and destabilization of liposomes. Biochemistry, 24 (1985) 3099-3106.
10. D.X. Liu, L. Huang, small but not large , unilamellar liposomes composed of dioleylphosphatidylethanolamine and oleic acid can be stabilized by human plasma. Biochemistry, 28 (1989) 7700-7707.
11. N. Duzgunes, S. Simoes, V. Slepushkin, E. Pretzer, J.J. Rossi, E. De Clercq, V.P. Antao, M.L. Coliins, M.C. de Lima, enhanced inhibition of HIV-I replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs delivered in pHsensitive liposomes, Nucleocides nucleotides nucleic acid 20 (2001) 515-523.
12. V.P. Torchilin, Recent advances with liposomes as pharmaceutical carriers. Nature 4, (2005) 145-160.
13. E. Matrobattista, G.A. Koning, L. van Bloois, A.C. Filipe W. Jiskoot, G. Storm, Functional characterization of an endosome disruptive peptide and its application in cytosolic delivery of immunoliposome- entrapped protieins. J. Biol. Chem. 277 (2002) 27135-27143.
14. C.J. Provoda, E.M. Stier, K.D. Lee, Tumor cell killing enabled by listeriolycin, O-Lyposome mediated delivery of the protein toxin, gelonin, J. Biol. Chem. 278, (2003) 35102-35108.
15. Ishida T, Okada Y, Kobayashi T, Kiwada H. Development of pH-sensitive liposomes that efficiently retain encapsulated doxorubicin in blood. Int. J. Pharmaceutics. 309 (2006) 94-100.